Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone in Advanced Germ Cell Tumors
NCT00070096Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in germ cell tumor (GCT), sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2003; status: completed.
02
Drugs
ixabepilone
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00070096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070096.